Zhejiang Orient Gene Biotech Co., Ltd. (688298.SH) announced that its subsidiaries, Shanghai Wanzijian Biotechnology Co., Ltd. and Healgen Scientific LLC (referred to as "Healgen"), have recently obtained medical device registration certificates for multiple products in China, Australia, and Singapore.
The newly certified products expand the company's flow fluorescence technology platform portfolio. Notably, the respiratory triple-test product enhances market accessibility in international markets, facilitating broader domestic and global expansion for related products.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.